Financial Sense Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,640
| Closed | -$201K | – | 113 |
|
|
2023
Q3 | $201K | Hold |
1,640
| – | – | 0.09% | 91 |
|
|
2023
Q2 | $208K | Hold |
1,640
| – | – | 0.09% | 85 |
|
|
2023
Q1 | $212K | Sell |
1,640
-1,180
| -42% | -$152K | 0.09% | 83 |
|
|
2022
Q4 | $370K | Buy |
+2,820
| New | +$370K | 0.15% | 77 |
|
|
2020
Q2 | – | Sell |
-14,975
| Closed | -$1.61M | – | 96 |
|
|
2020
Q1 | $1.61M | Buy |
+14,975
| New | +$1.61M | 0.72% | 26 |
|
|
2018
Q2 | – | Sell |
-3,417
| Closed | -$365K | – | 68 |
|
|
2018
Q1 | $365K | Sell |
3,417
-387
| -10% | -$41.3K | 0.18% | 56 |
|
|
2017
Q4 | $406K | Sell |
3,804
-390
| -9% | -$41.6K | 0.19% | 52 |
|
|
2017
Q3 | $466K | Buy |
4,194
+381
| +10% | +$42.3K | 0.24% | 44 |
|
|
2017
Q2 | $394K | Buy |
3,813
+138
| +4% | +$14.3K | 0.21% | 55 |
|
|
2017
Q1 | $359K | Buy |
3,675
+1,410
| +62% | +$138K | 0.22% | 50 |
|
|
2016
Q4 | $200K | Buy |
+2,265
| New | +$200K | 0.13% | 73 |
|